Guiding employees through cancer detection, care and recovery

Color is a virtual cancer clinic that provides oncologist-led support across the entire cancer journey, from early detection and diagnosis to treatment support and survivorship. Color combines clinical expertise with timely access to care, helping members get care sooner. This approach supports better outcomes and helps reduce the burden cancer places on members, their families and employers. Color has been shown to increase screening adherence by up to 77% and accelerate time to confirmed diagnosis by 66%.

Color offers three integrated programs:

Earlier Detection and Prevention Color identifies high-risk individuals through a guideline-based clinical assessment and helps members complete appropriate cancer screenings based on recommendations from organizations such as USPSTF, ACS and NCCN. Members receive personalized screening plans, at-home screening options when appropriate and clinical follow-up for abnormal results.

Active Treatment Management Members diagnosed with cancer receive support from an oncologist-led care team that works alongside local treating providers and the Priority Health care management team. Color helps coordinate care, manage symptoms, close care gaps, support treatment planning and provide access to clinical expertise throughout treatment.

Survivorship Care After treatment, Color helps cancer survivors manage long-term health, monitor for recurrence, address treatment-related side effects, support mental and physical well-being, and successfully return to work and daily life through survivorship-focused clinical care.

Color provides both cancer navigation and direct clinical care, pairing personalized guidance with access. Through Color Medical's nationwide team of oncologists, physicians, oncology nurses, dietitians, care advocates and survivorship specialists, members receive support with care coordination, treatment decisions, symptom management, testing, prescriptions and ongoing clinical care. Color also works closely with local providers and the Priority Health Care Management team to help ensure members receive timely, coordinated support.

GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software and automation to screen for cancer before symptoms appear.

The Galleri test screens for multiple cancers and can be taken annually as a simple blood draw.^4,5 The test can screen for many aggressive cancers before symptoms appear.⁶ In a clinical study, the Galleri test detected a signal shared by more than 50 types of cancer.⁷ The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. The Galleri test should be used in addition to healthcare provider recommended screening tests. See Important Safety Information and Laboratory/Test Information.

Cancers growing in the body shed DNA into the bloodstream. Although there are many types, the DNA fragments act like a unique fingerprint of cancer. ^3,4,5 The Galleri test can screen for many aggressive cancers before they become symptomatic,⁶ including those with no recommended screening.⁷ With this unique "fingerprint", the Galleri test helps to provide direction to your provider on the cancer’s origin and the next steps in diagnosis.⁸